Highlights of the 2009 Scientific Sessions of the European Society of Cardiology

Journal of the American College of Cardiology

Volumn 54, Issue 25, 2009, Pages 2447-2458

  Bax, Jeroen J ^a   Casadei, Barbara ^b   Di Mario, Carlo ^c   Fagard, Robert ^d   Filippatos, Gerasimos ^e   Fox, Keith A A ^f   Metra, Marco ^g   Nihoyannopoulos, Petros ^h   Perk, Joep ⁱ   Rademakers, Frank ^d   Rosenhek, Raphael ^j   Vardas, Panos E ^k   Pinto, Fausto J ^l   Ferrari, Roberto ^m  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^f ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY OF BRESCIA   (Italy)

^h HAMMERSMITH HOSPITAL   (United Kingdom)

ⁱ LINNAEUS UNIVERSITY   (Sweden)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

^k UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^l UNIVERSITY OF LISBON   (Portugal)

^m UNIVERSITY OF FERRARA   (Italy)

more..

Author keywords

annual congress of the ESC; cardiology highlights; European Society of Cardiology; scientific sessions

Indexed keywords

ACETYLSALICYLIC ACID; AMMONIA N 13; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARDIOVASCULAR AGENT; CK 1827452; CLOPIDOGREL; DABIGATRAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EVEROLIMUS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IVABRADINE; METFORMIN; PACLITAXEL; PLACEBO; PRASUGREL; PROTON PUMP INHIBITOR; RANOLAZINE; RAPAMYCIN; ROLOFYLLINE; ROSIGLITAZONE; ROSUVASTATIN; SULFONYLUREA; TICAGRELOR; UNCLASSIFIED DRUG; WARFARIN; ZOTAROLIMUS;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; BLEEDING; BRAIN HEMORRHAGE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL TRIAL; DEFIBRILLATOR; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG ELUTING STENT; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPEPSIA; EXERCISE; FIBRINOGEN BLOOD LEVEL; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART BEAT; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART PACING; HEART RATE; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; INFLAMMATION; INSULIN BLOOD LEVEL; LIFE STRESS; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL ACTIVITY; POSITRON EMISSION TOMOGRAPHY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RED WINE; REVIEW; SEIZURE; SMOKING; SPAIN; STENT THROMBOSIS; STROKE; VALVULAR HEART DISEASE; WINE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIAC PACING, ARTIFICIAL; CARDIOVASCULAR DISEASES; CRITICAL CARE; DIAGNOSTIC IMAGING; EUROPE; HUMANS; HYPOTHERMIA, INDUCED; MYOCARDIUM; PROGNOSIS; RISK FACTORS; STENTS;

EID: 71649102466     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.10.016     Document Type: Review

References (88)

1. Jensen M.T., Marott J.L., and Jensen G.B. Resting heart rate remains a risk factor for cardiovascular and non-cardiovascular mortality in healthy subjects after adjusting for inflammatory markers. The Copenhagen city heart study. Eur Heart J 30 Suppl (2009) 4 (abstr)
2. Plichart M., Thomas F., Empana J.P., et al. Trends in resting heart rate from 1991 to 2007 in 332,578 French adults. Eur Heart J 30 Suppl (2009) 961 (abstr)
3. Bura A., Labro S., Vaysse N., Thomas D., Boccalon H., and Cambou J.P. Impact of smoking prohibition in bars, restaurants and discotheques on employees endothelial function: the dilator study. Eur Heart J 30 Suppl (2009) 584 (abstr)
4. Pereg D., Gow R., Koren G., Lishner M., Van Uum S., and Mosseri M. Increased hair cortisol levels in patients with acute myocardial infarction. Eur Heart J 30 Suppl (2009) 967 (abstr)
5. Erbs S., Hoellriegel R., Linke A., et al. Generalized vascular damage and impaired endogenous regenerative capacity in children with obesity. Eur Heart J 30 Suppl (2009) 584 (abstr)
6. Walther C., Machaliza K., Mueller U., et al. Intensive exercise training leads to improved endothelial function in school children. Eur Heart J 30 Suppl (2009) 781 (abstr)
7. Werner C.M., Fuerster T., Widmann T., et al. Effects of endurance training on telomere length and senescence of circulating cells in professional athletes and matched controls without physical exercise. Eur Heart J 30 Suppl (2009) 853 (abstr)
8. Jones J., Mead A., Jennings C., et al. Changes in lifestyle and anthropometric measures in a novel family-centred community-based programme for cardiovascular disease prevention and rehabilitation. Eur Heart J 30 Suppl (2009) 74 (abstr)
9. Garzia A., Cameli M., Ballo P., et al. Right atrial enlargement, P-wave extension, PR and QTc intervals prolongation after acute red wine assumption. Eur Heart J 30 Suppl (2009) 238 (abstr)
10. Barone Adesi F., Vizzini L., Merletti F., and Richiardi L. It is just a game: lack of association between watching football matches and risk of acute cardiovascular events. Eur Heart J 30 Suppl (2009) 522 (abstr)
11. Federowski A., Stavenow L., Hedblad O., et al. Impaired orthostatic response predicts mortality and coronary events in middle-aged individuals. Eur Heart J 30 Suppl (2009) 11 (abstr)
12. Bombelli M., Toso E., Ganz F., et al. Relationship of morning blood pressure surge with cardiovascular events and total mortality in a general population. Eur Heart J 30 Suppl (2009) 11 (abstr)
13. Moelmen-Hansen H.E., Stolen T., Tjonna A.E., et al. Aerobic interval training decreases blood pressure more than moderate intensity training in patients with essential hypertension. Eur Heart J 30 Suppl (2009) 607 (abstr)
14. Beckett N.S., Peters R., Fletcher A., et al. Immediate benefit of treating very elderly hypertensives: results from an active-treatment extension to the Hypertension in the Very Elderly Trial (HYVET). Eur Heart J 30 Suppl (2009) 860 (abstr)
15. Kaminski K., Goode K.M., Zhang J., Clark A.L., and Cleland J.G.F. The effect of transient changes in laboratory parameters on distant mortality of patients hospitalized for heart failure. Eur Heart J 30 Suppl (2009) 139 (abstr)
16. Lassus J.P.E., Nieminen M.S., Peuhkurinen K., et al. Cystatin C as a marker of acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. Eur Heart J 30 Suppl (2009) 446 (abstr)
17. Jackson C.E., Bezlyak V., Tsorlalis I.K., et al. The novel biomarker red cell distribution width has incremental prognostic value, in addition to B-type natriuretic peptide, in patients with acute decompensated heart failure. Eur Heart J 30 Suppl (2009) 14 (abstr)
18. Reichlin T., Potocki M., Breidthardt T., et al. Minimally elevated cardiac troponin measured with a highly sensitive troponin assay and mortality in acute heart failure. Eur Heart J 30 Suppl (2009) 706 (abstr)
19. Peacock W.F., Nowak R., Neath S.X., et al. Emergency department short term mortality in acute heart failure: results of the international BACH trial. Eur Heart J 30 Suppl (2009) 163 (abstr)
20. Carson P.E., Komajda M., Zile M.R., et al. Predictors of outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in heart failure with preserved ejection fraction trial (I-Preserve). Eur Heart J 30 Suppl (2009) 865 (abstr)
21. Zile M.R., Gaasch W.H., Anand I., et al. Mode of death in patients with heart failure and a preserved ejection fraction: results from irbesartan heart failure with preserved ejection fraction study (I-Preserve) trial. Eur Heart J 30 Suppl (2009) 867 (abstr)
22. Home P.D., Pocock S.J., Beck-Nielsen H., et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet 119 (2009) 3125-3232
23. Fox K., Ford I., Steg P.G., Tendera M., Robertson M., and Ferrari R. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. Eur Heart J 30 (2009) 2337-2345
24. Maggioni A.P., Fabbri G., Lucci D., et al. Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial. Eur Heart J 30 (2009) 2327-2336
25. Dickstein K., Bogale N., Priori S., et al. The European cardiac resynchronization therapy survey. Eur Heart J 30 (2009) 2450-2460
26. Teerlink J.R., Metra M., Voors A.A., et al. Increased symptom-improvement with the novel vasodilator, relaxin, in acute heart failure patients with elevated blood pressure. Results from the Pre-RELAX-AHF study. Eur Heart J 30 Suppl (2009) 164 (abstr)
27. Felker G.M., Teerlink J.R., Ponikowski P., et al. Time to treatment and vasodilator efficacy in acute heart failure: results from the Pre-RELAX-AHF study. Eur Heart J 30 Suppl (2009) 424 (abstr)
28. Greenberg B., Chou W., Escandon R., et al. Phase II safety study evaluating the novel cardiac myosin activator, CK-1827452, in patients with ischemic cardiomyopathy and angina. Eur Heart J 30 Suppl (2009) 432 (abstr)
29. Jondeau G., Neuder Y., Eicher J.C., et al. B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode. Eur Heart J 30 (2009) 2186-2192
30. Giovannetti Ï., Dumas F., Lemiale V., et al. Causes and hospital mortality in a large cohort of out-of-hospital cardiac arrest. Eur Heart J 30 Suppl (2009) 608 (abstr)
31. Dumas F., Manzo-Silberman S., Giovannetti O., et al. Outcome after immediate invasive strategy in out-of-hospital cardiac arrest. Eur Heart J 30 Suppl (2009) 608 (abstr)
32. Salinas Sanguino P., Lopez De Sa E., Viana-Tejedor A., et al. Electrocardiographic disturbances induced by mild therapeutic hypothermia after cardiac arrest. Eur Heart J 30 Suppl (2009) 20 (abstr)
33. Meerkin D., Lownie S.P., Prestigiacomo C.J., and Solar R.J. In vivo systemic effects of catheter based selective unilateral profound cerebral hypothermia. Eur Heart J 30 Suppl (2009) 20 (abstr)
34. Tuseth V., Pettersen R.J., Grong K., et al. Randomized comparison of percutaneous left ventricular assist device with open chest cardiac massage and surgical left ventricular assist device in ischemic cardiac arrest. Eur Heart J 30 Suppl (2009) 21 (abstr)
35. O'Donoghue M.L., Braunwald E., Antman E.M., et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet 374 (2009) 989-997
36. Wallentin L., Becker R.C., Budaj A., et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361 (2009) 1045-1057
37. De La Torre Hernandez J.M., Gimeno F., Diarte J.A., et al., ESTROFA Study Group. Thrombosis in real practice with second generation drug-eluting stents. Results from the ESTROFA-2 Spanish registry. Eur Heart J 30 Suppl (2009) 461 (abstr)
38. Byrne R.A., Kastrati A., Kufner S., et al. ISAR-TEST-4 study: randomized non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus Eluting Stents (ISAR TEST 4 Trial). Eur Heart J (2009) In press
39. Nasu K., Terashima M., Tsuchikane E., et al. Difference in neointimal coverage on the stent strut between sirolimus- and paclitaxel-eluting stents: optical coherence tomography analysis. Eur Heart J 30 Suppl (2009) 592 (abstr)
40. Miyoshi N., Shite J., Otake H., et al. Comparison of paclitaxel-eluting stent with sirolimus-eluting stent by optical coherence tomography: implanting two different types of drug-eluting stent in a single coronary artery. Eur Heart J 30 Suppl (2009) 593 (abstr)
41. Bøhmer E., Hoffmann P., Abdelnoor M., Arnesen H., and Halvorsen S. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances: results of the NORDISTEMI (NORwegian study on District treatment of ST-Elevation Myocardial Infarction). J Am Coll Cardiol (2009 Sep 10) [E-pub ahead of print]
42. Jadidi A., Forclaz A., and Miyazaki S. Left atrial high density mapping during sinus rhythm, coronary sinus pacing and atrial fibrillation: evidence of rhythm dependent (functional) fractionation. Eur Heart J 30 Suppl (2009) 600 (abstr)
43. Sossalla S., Kallmeyer B., Wagner S., et al. Atrial fibrillation leads to electrical remodelling of Na currents. Role of INa inhibition by ranolazine on arrhythmias and contractility. Eur Heart J 30 Suppl (2009) 152 (abstr)
44. Benito B., Campuzano O., Ishac R., et al. Role of genetic testing in risk stratification of Brugada syndrome. Eur Heart J 30 Suppl (2009) 886 (abstr)
45. Bajpai A., Eruchie D., Asrress K., et al. Early use of implantable loop recorders in the assessment of patients presenting to secondary care with syncope or severe palpitations with pre-syncope. Eur Heart J 30 Suppl (2009) 16 (abstr)
46. Petkar S., Iddon P., Bell W., et al. REVISE (Reveal in the Investigation of Syncope and Epilepsy) study. Eur Heart J 30 Suppl (2009) 15 (abstr)
47. De Ruvo E., De Luca L., Gargaro A., et al. Relative risk of delayed detection of adverse events with standard in-office follow-up program versus home monitoring remote control in patients with cardiac resynchronization therapy ICD. Eur Heart J 30 Suppl (2009) 911 (abstr)
48. Varma N., Epstein A., Irimpen A., et al. Event notifications by remote monitoring systems performing automatic daily checks: load, characteristics and clinical utility. Eur Heart J 30 Suppl (2009) 307 (abstr)
49. Chen X., Svendsen J., and Pehrson S. Acute and long-term outcome of remote magnetic navigation for ablation of atrial fibrillation using a magnetic irrigated ablation catheter. Eur Heart J 30 Suppl (2009) 270 (abstr)
50. Pezawas T., Schukro C., Stix G., et al. Long-term results of remote-controlled magnetic navigation for pulmonary vein isolation and differences compared with hand-navigated ablation of atrial fibrillation. Eur Heart J 30 Suppl (2009) 909 (abstr)
51. Sommer P., Piorkowski C., Arya A., et al. Significantly improved left ventricular ejection fraction after ablation of atrial fibrillation in patients with heart failure and impaired LV function. Eur Heart J 30 Suppl (2009) 120 (abstr)
52. Probst V., Veltmann C., Eckardt L., et al. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada registry. Eur Heart J 30 Suppl (2009) 886 (abstr)
53. Moss A.J., Hall W.J., Cannom D.S., et al. Cardiac resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361 (2009) 1329-1338
54. Linde C., Leman R., Daubert J.C., et al. CRT in mild heart failure: differences in outcomes between NYHA class I and II patients over 24 months of CRT. Results from the European cohort of the REVERSE trial. Eur Heart J 30 Suppl (2009) 13 (abstr)
55. Gold M., Linde C., Lozano I., et al. Relationship of QRS duration to reverse remodelling with CRT in mild heart failure over 2 years. Results from the European cohort of the REVERSE trial. Eur Heart J 30 Suppl (2009) 13 (abstr)
56. Van Bommel R.J., Bax J.J., Abraham W.T., et al. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J 30 (2009) 2470-2477
57. Connolly S.J., Ezekowitz M.D., Yusuf S., et al. Dabigratan versus warfarin in patients with atrial fibrillation. N Engl J Med 361 (2009) 1139-1151
58. Moya A., Sutton R., Ammirati F., et al. Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Eur Heart J 30 (2009) 2631-2671
59. Bruder O., Schneider S., Nothnagel D., et al. EuroCMR (European cardiovascular magnetic resonance) registry: results of the German pilot phase. J Am Coll Cardiol 54 (2009) 1457-1466
60. Yilmaz A., Mahrholdt H., Athanasiadis A., et al. Diagnostic value of perfusion-CMR in patients with angina pectoris but normal coronary angiograms assessed by intracoronary acetylcholine-testing. Eur Heart J 30 Suppl (2009) 877 (abstr)
61. Eitel I., Fuernau G., Sareban M., et al. Determinants and clinical impact of myocardial salvage assessed by magnetic resonance imaging in patients with STEMI undergoing primary PCI. Eur Heart J 30 Suppl (2009) 201 (abstr)
62. Masci P.G., Ganame J., Strata E., et al. Clinical correlates of myocardial salvage index in acute ST-segment elevation myocardial infarction: a cardiac magnetic resonance imaging study. Eur Heart J 30 Suppl (2009) 179 (abstr)
63. Herzog B.A., Husmann L., Buechel R.R., et al. Long-term prognostic value of coronary flow reserve assessed with 13N-ammonia PET. Eur Heart J 30 Suppl (2009) 29 (abstr)
64. Mazurek T., Kobylecka M., Kochman J., et al. Peri-coronary adipose tissue inflammation affects coronary atherosclerosis in patients with stable angina. Eur Heart J 30 Suppl (2009) 28 (abstr)
65. De Vos C.B., Crijns H.J., Pisters R., et al. Tissue velocity imaging of the cyclic atrial fibrillatory wall motion predicts short- and long-term outcome of electrical cardioversion. Eur Heart J 30 Suppl (2009) 630 (abstr)
66. Cortigiani L., Sicari R., Bigi R., et al. Prognostic implication of stress echocardiography result in hypertensives and normotensives. A study in 10,054 patients. Eur Heart J 30 Suppl (2009) 320 (abstr)
67. Jenkins C., Stanton T., and Marwick T.H. Association of outcome with left ventricular parameters measured by two- and three-dimensional echocardiography. Eur Heart J 30 Suppl (2009) 149 (abstr)
68. Stanton T., Leano R., and Marwick T.H. Global longitudinal strain is superior to ejection fraction and wall motion scoring for the prediction of mortality. Eur Heart J 30 Suppl (2009) 319 (abstr)
69. Lommi J.L., Kovanen P.T., Jauhianen M., et al. High-density lipoproteins (HDL) are present in stenotic aortic valves and may protect them against calcification. Eur Heart J 30 Suppl (2009) 997 (abstr)
70. Rajamannan N., Rosenhek R., and Rahimtoola S. Atorvastatin attenuates severe myxomatous mitral regurgitation via Lrp5/Sox9 chondrocyte formation. Eur Heart J 30 Suppl (2009) 997 (abstr)
71. Herrmann S.H., Strotmann J.S., Niemann M.N., et al. The impact of myocardial fibrosis on regional myocardial function and clinical outcome in patients with low gradient aortic valve stenosis. Eur Heart J 30 Suppl (2009) 455 (abstr)
72. Cueff C., Serfaty J.M., Cimadevilla C., et al. Aortic valve calcification measured by multislice computed tomography in aortic stenosis-correlation with hemodynamic severity and clinical implication for patients with low ejection fraction. Eur Heart J 30 Suppl (2009) 681 (abstr)
73. Monin J.L., Lancellotti P., Monchi M., et al. A risk score for predicting outcome in patients with asymptomatic aortic stenosis. Eur Heart J 30 Suppl (2009) 896 (abstr)
74. Rosenhek R., Zilberszac R., Mundigler G., et al. Is early elective surgery warranted in very severe aortic stenosis?. Eur Heart J 30 Suppl (2009) 897 (abstr)
75. Llibre Pallares C., Rodriquez Palomares J.F., Abdul-Jawad Altisent O., et al. Transthoracic echocardiography versus computed tomography in the evaluation of the ascending aorta diameters in aortic valve disease. Eur Heart J 30 Suppl (2009) 678 (abstr)
76. Himbert D., Descoutures F., Al-Attar N., et al. Results of a strategy integrating transfemoral and transapical aortic valve implantation in high-risk patients with aortic stenosis. Eur Heart J 30 Suppl (2009) 894 (abstr)
77. Taramasso M., Maisano F., Michev I., et al. Transcatheter aortic valve implantation in patients with low Euroscore but presenting with anatomical or technical contraindications to conventional surgery. Eur Heart J 30 Suppl (2009) 895 (abstr)
78. Habib G., Hoen B., Tornos P., et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 30 (2009) 2369-2413
79. Holm H., Arnar D.O., Gudbjartsson D.F., et al. A sequence variant in the ZFHX3 gene on chromosome 16p22 associates with atrial fibrillation and ischemic stroke. Eur Heart J 30 Suppl (2009) 602 (abstr)
80. Agabiti-Rosei C., Withers S.B., Greenstein A., et al. Influencing the anticontractile properties of adipose tissue: the effects of aldosterone, its antagonists and hypoxia. Eur Heart J 30 Suppl (2009) 507 (abstr)
81. Antonopoulos A.S., Antoniades C., Tousoulis D., et al. Polymorphism on adiponectin gene regulates the expression of adiponectin in adipose tissue and affects arterial superoxide generation in patients with advanced atherosclerosis. Eur Heart J 30 Suppl (2009) 761 (abstr)
82. Takase H., Dohi Y., Toriyama T., et al. Oxidative stress reflects visceral fat accumulation in apparently healthy subjects. Eur Heart J 30 Suppl (2009) 777 (abstr)
83. Antoniades C., Bakogiannis C., Tousoulis D., et al. Interaction between vascular redox state and adiponectin synthesis from perivascular adipose tissue, in human atherosclerosis. Eur Heart J 30 Suppl (2009) 960 (abstr)
84. Kurokawa S., Niwano S., Niwano H., et al. Process of the progression of ventricular remodeling and arrhythmia in the systemic hyper-oxidative state. A study in glutathione depleted rat model. Eur Heart J 30 Suppl (2009) 67 (abstr)
85. Ikonomidis I., Tzortzis S., Lekakis J., et al. Association of endothelial function and nitrooxidative stress with speckle tracking myocardial deformation in patients with rheumatoid arthritis. Effects of chronic inhibition of interleukin-1. Eur Heart J 30 Suppl (2009) 360 (abstr)
86. Zimmer S., Paez-Maletz I., Laufs U., Nickenig G., and Wassmann S. Reduction of vascular oxidative stress, improvement of endothelial function, and attenuation of atherosclerotic plaque development by chronic inhibition of rac-1 GTPase in mice. Eur Heart J 30 Suppl (2009) 758 (abstr)
87. Adam O., Theobald K., Grube M., Kroemer H.K., Boehm M., and Laufs U. Role of lysyl oxidase for atrial fibrosis in atrial fibrillation. Eur Heart J 30 Suppl (2009) 600 (abstr)
88. Rahimi K., Emberson J., McGale P., et al. Effect of statins on atrial fibrillation: a collaborative meta-analysis of randomised controlled trials. Eur Heart J 30 Suppl (2009) 450 (abstr)